Viking Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC VKTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

700,295

Value ($000)

24,636

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	24,636	0.0%	700,295	12/31/2025
2025 Q3	11/10/2025	18,336	0.0%	697,708	9/30/2025
2025 Q2	8/12/2025	19,277	0.0%	727,420	6/30/2025
2025 Q1	9/15/2025	17,192	0.0%	711,897	3/31/2025
2024 Q4	2/6/2025	29,321	0.0%	728,652	12/31/2024
2024 Q3	11/12/2024	45,304	0.0%	715,597	9/30/2024
2024 Q2	8/12/2024	35,595	0.0%	671,475	6/30/2024
2024 Q1	5/9/2024	68,797	0.0%	838,984	3/31/2024
2023 Q4	2/6/2024	14,436	0.0%	775,699	12/31/2023
2023 Q3	11/8/2023	8,472	0.0%	765,320	9/30/2023
2023 Q2	8/10/2023	4,210	0.0%	259,742	6/30/2023
2023 Q1	5/12/2023	611	0.0%	36,668	3/31/2023
2022 Q4	2/13/2023	272	0.0%	28,966	12/31/2022
2022 Q3	11/14/2022	79	0.0%	28,966	9/30/2022
2022 Q2	8/15/2022	129	0.0%	44,466	6/30/2022
2022 Q1	5/13/2022	590	0.0%	196,410	3/31/2022
2021 Q4	2/11/2022	816	0.0%	177,326	12/31/2021
2021 Q3	11/16/2021	1,081	0.0%	172,095	9/30/2021
2021 Q2	8/16/2021	1,028	0.0%	171,539	6/30/2021
2021 Q1	5/17/2021	1,053	0.0%	166,455	3/31/2021
2020 Q4	2/16/2021	874	0.0%	155,083	12/31/2020
2020 Q3	11/13/2020	905	0.0%	155,347	9/30/2020
2020 Q2	8/20/2020	1,165	0.0%	161,478	6/30/2020
2020 Q1	5/15/2020	787	0.0%	168,153	3/31/2020
2019 Q4	2/7/2020	1,323	0.0%	164,950	12/31/2019